Sarepta Gains as FDA Official Overrules Staff to Approve Therapy

(Bloomberg) — A top US Food and Drug Administration official overrode reviewers to give broad approval to Sarepta Therapeutics Inc.’s gene therapy for a rare muscle disease in children, despite a lack of data showing it actually slows overall progression of the disease.

Most Read from…